RI91 Pill - yellow oval, 15mm
Pill with imprint RI91 is Yellow, Oval and has been identified as Minocycline Hydrochloride 100 mg. It is supplied by Ranbaxy Pharmaceuticals Inc.
Minocycline is used in the treatment of Bacterial Infection; Acne; Bartonellosis; Bullous Pemphigoid; Actinomycosis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Minocycline 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RI91


Minocycline Hydrochloride
- Imprint
- RI91
- Strength
- 100 mg
- Color
- Yellow
- Size
- 15.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- Tetracyclines
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ranbaxy Pharmaceuticals Inc.
- Inactive Ingredients
-
crospovidone,
lactose monohydrate,
polyethylene glycol 6000,
stearic acid,
titanium dioxide,
ferric oxide yellow,
microcrystalline cellulose,
silicon dioxide,
magnesium stearate,
hypromelloses
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
13668-0487 | Torrent Pharmaceuticals Limited |
63304-0699 | Ranbaxy Pharmaceuticals Inc. |
More about minocycline
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (564)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: tetracyclines
- Breastfeeding
- En español
Patient resources
- Minocycline drug information
- Minocycline (Intravenous) (Advanced Reading)
- Minocycline Capsules and Tablets
- Minocycline Extended-Release Tablets
Other brands
Minocin, Emrosi, Dynacin, Ximino, ... +3 more
Professional resources
- Minocycline monograph
- Minocycline (EENT) (AHFS Monograph)
- Minocycline (FDA)
- Minocycline Capsules (FDA)
- Minocycline Extended Release Tablets (FDA)
Other brands
Minocin, Emrosi, Ximino, Minocin for Injection, ... +2 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.